Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.

BACKGROUND: Effective therapy for HIV-infected individuals remains an unmet medical need. Promising clinical trials with dendritic cell (DC)-based immunotherapy consisting of autologous DC loaded with autologous virus have been reported, however, these approaches depend on large numbers of HIV virio...

Full description

Bibliographic Details
Main Authors: Irina Tcherepanova, Jason Harris, Aijing Starr, Jaclyn Cleveland, Helen Ketteringham, David Calderhead, Joe Horvatinovich, Don Healey, Charles A Nicolette
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2211536?pdf=render
_version_ 1831772779251236864
author Irina Tcherepanova
Jason Harris
Aijing Starr
Jaclyn Cleveland
Helen Ketteringham
David Calderhead
Joe Horvatinovich
Don Healey
Charles A Nicolette
author_facet Irina Tcherepanova
Jason Harris
Aijing Starr
Jaclyn Cleveland
Helen Ketteringham
David Calderhead
Joe Horvatinovich
Don Healey
Charles A Nicolette
author_sort Irina Tcherepanova
collection DOAJ
description BACKGROUND: Effective therapy for HIV-infected individuals remains an unmet medical need. Promising clinical trials with dendritic cell (DC)-based immunotherapy consisting of autologous DC loaded with autologous virus have been reported, however, these approaches depend on large numbers of HIV virions to generate sufficient doses for even limited treatment regimens. METHODOLOGY/PRINCIPAL FINDINGS: The present study describes a novel approach for RT-PCR amplification of HIV antigens. Previously, RT-PCR amplification of autologous viral sequences has been confounded by the high mutation rate of the virus which results in unreliable primer-template binding. To resolve this problem we developed a multiplex RT-PCR strategy that allows reliable strain-independent amplification of highly polymorphic target antigens from any patient and requires neither viral sequence data nor custom-designed PCR primers for each individual. We demonstrate the application of our RT-PCR process to amplify translationally-competent RNA encoding regions of Gag, Vpr, Rev and Nef. The products amplified using this method represent a complex mixture of autologous antigens encoded by viral quasispecies. We further demonstrate that DCs electroporated with in vitro-transcribed HIV RNAs are capable of stimulating poly-antigen-specific CD8+ T cell responses in vitro. CONCLUSION/SIGNIFICANCE: This study describes a strategy to overcome patient to patient viral diversity enabling strain-independent RT-PCR amplification of RNAs encoding sequence divergent quasispecies of Gag, Vpr, Rev and Nef from small volumes of infectious plasma. The approach allows creation of a completely autologous therapy that does not require advance knowledge of the HIV genomic sequences, does not have yield limitations and has no intact virus in the final product. The simultaneous use of autologous viral antigens and DCs may provoke broad patient-specific immune responses that could potentially induce effective control of viral loads in the absence of conventional antiretroviral drug therapy.
first_indexed 2024-12-22T08:23:13Z
format Article
id doaj.art-ab365b7828974df5a523641a15f0addc
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T08:23:13Z
publishDate 2008-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ab365b7828974df5a523641a15f0addc2022-12-21T18:32:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-01-0131e148910.1371/journal.pone.0001489Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.Irina TcherepanovaJason HarrisAijing StarrJaclyn ClevelandHelen KetteringhamDavid CalderheadJoe HorvatinovichDon HealeyCharles A NicoletteBACKGROUND: Effective therapy for HIV-infected individuals remains an unmet medical need. Promising clinical trials with dendritic cell (DC)-based immunotherapy consisting of autologous DC loaded with autologous virus have been reported, however, these approaches depend on large numbers of HIV virions to generate sufficient doses for even limited treatment regimens. METHODOLOGY/PRINCIPAL FINDINGS: The present study describes a novel approach for RT-PCR amplification of HIV antigens. Previously, RT-PCR amplification of autologous viral sequences has been confounded by the high mutation rate of the virus which results in unreliable primer-template binding. To resolve this problem we developed a multiplex RT-PCR strategy that allows reliable strain-independent amplification of highly polymorphic target antigens from any patient and requires neither viral sequence data nor custom-designed PCR primers for each individual. We demonstrate the application of our RT-PCR process to amplify translationally-competent RNA encoding regions of Gag, Vpr, Rev and Nef. The products amplified using this method represent a complex mixture of autologous antigens encoded by viral quasispecies. We further demonstrate that DCs electroporated with in vitro-transcribed HIV RNAs are capable of stimulating poly-antigen-specific CD8+ T cell responses in vitro. CONCLUSION/SIGNIFICANCE: This study describes a strategy to overcome patient to patient viral diversity enabling strain-independent RT-PCR amplification of RNAs encoding sequence divergent quasispecies of Gag, Vpr, Rev and Nef from small volumes of infectious plasma. The approach allows creation of a completely autologous therapy that does not require advance knowledge of the HIV genomic sequences, does not have yield limitations and has no intact virus in the final product. The simultaneous use of autologous viral antigens and DCs may provoke broad patient-specific immune responses that could potentially induce effective control of viral loads in the absence of conventional antiretroviral drug therapy.http://europepmc.org/articles/PMC2211536?pdf=render
spellingShingle Irina Tcherepanova
Jason Harris
Aijing Starr
Jaclyn Cleveland
Helen Ketteringham
David Calderhead
Joe Horvatinovich
Don Healey
Charles A Nicolette
Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.
PLoS ONE
title Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.
title_full Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.
title_fullStr Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.
title_full_unstemmed Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.
title_short Multiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infection.
title_sort multiplex rt pcr amplification of hiv genes to create a completely autologous dc based immunotherapy for the treatment of hiv infection
url http://europepmc.org/articles/PMC2211536?pdf=render
work_keys_str_mv AT irinatcherepanova multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT jasonharris multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT aijingstarr multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT jaclyncleveland multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT helenketteringham multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT davidcalderhead multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT joehorvatinovich multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT donhealey multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection
AT charlesanicolette multiplexrtpcramplificationofhivgenestocreateacompletelyautologousdcbasedimmunotherapyforthetreatmentofhivinfection